Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Moderna, Inc. MRNA

Healthcare  —  Biotechnology
198.88 4.06 2.08% as of 25 Sep
Market cap
$78.8B
P/E
0.0×
S&P 500 Member
Indexes indicate stock being part of an index
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Moderna, Inc. (MRNA) Return on invested capital

Moderna, Inc.'s return on invested capital over the twelve months to 30 June 2026 was −93.5%, down 38.0 percentage points from fiscal 2025 (−55.5%). Over the past ten years it has ranged from −626.6% (fiscal 2018) to 206.9% (fiscal 2021); the current reading is higher than 40% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.

Return on invested capital, annual

Annual

Period Return on invested capital Change (points)
FY2025 −55.5% 7.47
FY2024 −63.0% (17.50)
FY2023 −45.5% (103.58)
FY2022 58.1% (148.77)
FY2021 206.9% 206.87
FY2020 0.00% 311.74
FY2019 −311.7% 314.89
FY2018 −626.6% (626.63)
FY2017 0.00% 0.00
FY2016 0.00% —

Against its own ten years

Low −626.6% High 206.9%
Ten-year median −22.7%
Current reading's percentile 40

Return on invested capital against peers

Company Return on invested capital
ONC BeOne Medicines Ltd. - Sponsored ADR compare 60.2%
VRTX Vertex Pharmaceuticals Incorporated compare 24.1%
ARGX argenex SE compare 20.7%
REGN Regeneron Pharmaceuticals, Inc. compare 9.34%
RPRX Royalty Pharma PLC compare 5.28%
ALNY Alnylam Pharmaceuticals, Inc. compare 0.00%
RVMD Revolution Medicines, Inc. compare 0.00%
MRNA Moderna, Inc. −93.5%
INSM Insmed, Inc. compare −329.2%
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on MRNA